Vitamin K antagonists, or Coumarins, are a common and effective way of dealing with issues related to stroke, however genetic variation can cause issues in some individuals who can have an adverse reaction to oral anticoagulants. The PGX-Thrombo StripAssay® is the key to identifying those individuals who may not react to the drug in the appropriate way or may respond badly, thereby allowing an immediate course and thus allow a course of treatment that maximizes effectiveness.
PGX-Thrombo StripAssay® Catalog 4-730
(-1639 G>A) in the VKORC1 promoter
CYP2C9 alleles *1,*2, and *3